0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Treatment of Late-Stage Syphilis

Aram S. A. van Brussel, MD, PhD1; Gijs W. D. Landman, MD, PhD1
[+] Author Affiliations
1Gelre Hospital Apeldoorn, Utrecht, the Netherlands
JAMA. 2015;313(9):968-969. doi:10.1001/jama.2015.0669.
Text Size: A A A
Published online

Extract

To the Editor Dr Clement and colleagues1 reviewed the available literature on treatment for the early and late stages of syphilis and concluded that benzathine penicillin G is the established treatment for early syphilis (grade A level of evidence). Scarce data are available on treatment of more advanced stages, such as neurosyphilis. Intravenous administration of penicillin G achieves adequate cerebrospinal fluid (CSF) levels and is currently the treatment of choice for neurosyphilis. We noticed that the role of an old drug, probenecid, was hardly mentioned in the review, although it could have a role in treating neurosyphilis.

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

March 3, 2015
Meredith E. Clement, MD; N. Lance Okeke, MD; Charles B. Hicks, MD
1Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina
2Division of Infectious Diseases, University of California, San Diego
JAMA. 2015;313(9):969-970. doi:10.1001/jama.2015.0675.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

606 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();